United States Bevacizumab Market Report 2016

Publisher Name :
Date: 12-Dec-2016
No. of pages: 101
Inquire Before Buying

Notes:

Sales, means the sales volume of Bevacizumab

Revenue, means the sales value of Bevacizumab

This report studies sales (consumption) of Bevacizumab in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer

- Biocon

- Bionomics

- Amgen

- Genexine

- Levolta Pharmaceuticals

- Enzon Pharmaceuticals

- Marsala Biotech

- Mabtech

- Fujifilm Kyowa Kirin Biologics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Bevacizumab in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Bevacizumab Market Report 2016

Table of Contents
United States Bevacizumab Market Report 2016
1 Bevacizumab Overview
1.1 Product Overview and Scope of Bevacizumab
1.2 Classification of Bevacizumab
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Bevacizumab
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Bevacizumab (2011-2021)
1.4.1 United States Bevacizumab Sales and Growth Rate (2011-2021)
1.4.2 United States Bevacizumab Revenue and Growth Rate (2011-2021)
2 United States Bevacizumab Competition by Manufacturers
2.1 United States Bevacizumab Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Bevacizumab Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Bevacizumab Average Price by Manufactures (2015 and 2016)
2.4 Bevacizumab Market Competitive Situation and Trends
2.4.1 Bevacizumab Market Concentration Rate
2.4.2 Bevacizumab Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Bevacizumab Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Bevacizumab Sales and Market Share by Type (2011-2016)
3.2 United States Bevacizumab Revenue and Market Share by Type (2011-2016)
3.3 United States Bevacizumab Price by Type (2011-2016)
3.4 United States Bevacizumab Sales Growth Rate by Type (2011-2016)
4 United States Bevacizumab Sales (Volume) by Application (2011-2016)
4.1 United States Bevacizumab Sales and Market Share by Application (2011-2016)
4.2 United States Bevacizumab Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Bevacizumab Manufacturers Profiles/Analysis
5.1 Pfizer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Bevacizumab Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Biocon
5.2.2 Bevacizumab Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Biocon Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Bionomics
5.3.2 Bevacizumab Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Bionomics Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Amgen
5.4.2 Bevacizumab Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Amgen Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Genexine
5.5.2 Bevacizumab Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Genexine Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Levolta Pharmaceuticals
5.6.2 Bevacizumab Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Levolta Pharmaceuticals Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Enzon Pharmaceuticals
5.7.2 Bevacizumab Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Enzon Pharmaceuticals Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Marsala Biotech
5.8.2 Bevacizumab Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Marsala Biotech Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Mabtech
5.9.2 Bevacizumab Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Mabtech Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Fujifilm Kyowa Kirin Biologics
5.10.2 Bevacizumab Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Fujifilm Kyowa Kirin Biologics Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Bevacizumab Manufacturing Cost Analysis
6.1 Bevacizumab Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Bevacizumab
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Bevacizumab Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Bevacizumab Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Bevacizumab Market Forecast (2016-2021)
10.1 United States Bevacizumab Sales, Revenue Forecast (2016-2021)
10.2 United States Bevacizumab Sales Forecast by Type (2016-2021)
10.3 United States Bevacizumab Sales Forecast by Application (2016-2021)
10.4 Bevacizumab Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Bevacizumab
Table Classification of Bevacizumab
Figure United States Sales Market Share of Bevacizumab by Type in 2015
Table Application of Bevacizumab
Figure United States Sales Market Share of Bevacizumab by Application in 2015
Figure United States Bevacizumab Sales and Growth Rate (2011-2021)
Figure United States Bevacizumab Revenue and Growth Rate (2011-2021)
Table United States Bevacizumab Sales of Key Manufacturers (2015 and 2016)
Table United States Bevacizumab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bevacizumab Sales Share by Manufacturers
Figure 2016 Bevacizumab Sales Share by Manufacturers
Table United States Bevacizumab Revenue by Manufacturers (2015 and 2016)
Table United States Bevacizumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Bevacizumab Revenue Share by Manufacturers
Table 2016 United States Bevacizumab Revenue Share by Manufacturers
Table United States Market Bevacizumab Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Bevacizumab Average Price of Key Manufacturers in 2015
Figure Bevacizumab Market Share of Top 3 Manufacturers
Figure Bevacizumab Market Share of Top 5 Manufacturers
Table United States Bevacizumab Sales by Type (2011-2016)
Table United States Bevacizumab Sales Share by Type (2011-2016)
Figure United States Bevacizumab Sales Market Share by Type in 2015
Table United States Bevacizumab Revenue and Market Share by Type (2011-2016)
Table United States Bevacizumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Bevacizumab by Type (2011-2016)
Table United States Bevacizumab Price by Type (2011-2016)
Figure United States Bevacizumab Sales Growth Rate by Type (2011-2016)
Table United States Bevacizumab Sales by Application (2011-2016)
Table United States Bevacizumab Sales Market Share by Application (2011-2016)
Figure United States Bevacizumab Sales Market Share by Application in 2015
Table United States Bevacizumab Sales Growth Rate by Application (2011-2016)
Figure United States Bevacizumab Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Bevacizumab Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Bevacizumab Sales Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionomics Bevacizumab Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Bevacizumab Sales Market Share (2011-2016)
Table Genexine Basic Information List
Table Genexine Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genexine Bevacizumab Sales Market Share (2011-2016)
Table Levolta Pharmaceuticals Basic Information List
Table Levolta Pharmaceuticals Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Levolta Pharmaceuticals Bevacizumab Sales Market Share (2011-2016)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Enzon Pharmaceuticals Bevacizumab Sales Market Share (2011-2016)
Table Marsala Biotech Basic Information List
Table Marsala Biotech Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Marsala Biotech Bevacizumab Sales Market Share (2011-2016)
Table Mabtech Basic Information List
Table Mabtech Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mabtech Bevacizumab Sales Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Bevacizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Bevacizumab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bevacizumab
Figure Manufacturing Process Analysis of Bevacizumab
Figure Bevacizumab Industrial Chain Analysis
Table Raw Materials Sources of Bevacizumab Major Manufacturers in 2015
Table Major Buyers of Bevacizumab
Table Distributors/Traders List
Figure United States Bevacizumab Production and Growth Rate Forecast (2016-2021)
Figure United States Bevacizumab Revenue and Growth Rate Forecast (2016-2021)
Table United States Bevacizumab Production Forecast by Type (2016-2021)
Table United States Bevacizumab Consumption Forecast by Application (2016-2021)
  • Asia-Pacific Thin Film Drugs Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 109
    In this report, the Asia-Pacific Thin Film Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Thin Film Drugs for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Ta......
  • Asia-Pacific Placental Protein Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the Asia-Pacific Placental Protein market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (KG), revenue (Million USD), market share and growth rate of Placental Protein for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - T......
  • Asia-Pacific Placenta Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the Asia-Pacific Placenta market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (KG), revenue (Million USD), market share and growth rate of Placenta for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan - Ind......
  • Asia-Pacific Placenta Extract Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the Asia-Pacific Placenta Extract market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (KG), revenue (Million USD), market share and growth rate of Placenta Extract for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Tai......
  • Asia-Pacific Hydrolyzed Placental Protein Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 103
    In this report, the Asia-Pacific Hydrolyzed Placental Protein market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (KG), revenue (Million USD), market share and growth rate of Hydrolyzed Placental Protein for these regions, from 2012 to 2022 (forecast), including - China - Japan - ......
  • Asia-Pacific Human Placental Protein Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Human Placental Protein market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (KG), revenue (Million USD), market share and growth rate of Human Placental Protein for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Kore......
  • Asia-Pacific Human Chorionic Gonadotropin (HCG) Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Human Chorionic Gonadotropin (HCG) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (KG), revenue (Million USD), market share and growth rate of Human Chorionic Gonadotropin (HCG) for these regions, from 2012 to 2022 (forecast), including - China - Jap......
  • Asia-Pacific Chorionic Gonadotropin Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the Asia-Pacific Chorionic Gonadotropin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (KG), revenue (Million USD), market share and growth rate of Chorionic Gonadotropin for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea......
  • Asia-Pacific Brewers Peptone Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the Asia-Pacific Brewers Peptone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (KG), revenue (Million USD), market share and growth rate of Brewers Peptone for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwa......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs